Cited in:


This article has been cited by:

  1. You have free access to this content1
    Nellie A. Martin, Zsolt Illes, Differentially expressed microRNA in multiple sclerosis: A window into pathogenesis?, Clinical and Experimental Neuroimmunology, 2014, 5, 2
  2. 2
    Dimitry N. Krementsov, Rajkumar Noubade, Julie A. Dragon, Kinya Otsu, Mercedes Rincon, Cory Teuscher, Sex-specific control of central nervous system autoimmunity by p38 mitogen-activated protein kinase signaling in myeloid cells, Annals of Neurology, 2014, 75, 1
  3. 3
    James Dooley, Michelle A. Linterman, Adrian Liston, MicroRNA regulation of T-cell development, Immunological Reviews, 2013, 253, 1
  4. 4
    Hanieh Hamza, Alzahrani Abdullah, MicroRNA-132 suppresses autoimmune encephalomyelitis by inducing cholinergic anti-inflammation: A new Ahr-based exploration, European Journal of Immunology, 2013, 43, 10
  5. 5
    Ameneh Zare-Shahabadi, Yves Renaudineau, Nima Rezaei, MicroRNAs and multiple sclerosis: from physiopathology toward therapy, Expert Opinion on Therapeutic Targets, 2013, 17, 12, 1497


  6. 6
    M. Plank, S. Maltby, J. Mattes, P. S. Foster, Targeting translational control as a novel way to treat inflammatory disease: the emerging role of MicroRNAs, Clinical & Experimental Allergy, 2013, 43, 9